Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation

被引:44
作者
Gilbert, Jessica R. [1 ]
Zarate, Carlos A., Jr. [1 ]
机构
[1] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, 10 Ctr Dr,MSC 1282, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Ketamine; Electrophysiology; Gamma; Long-term potentiation; Dynamic causal modeling; NMDA RECEPTOR BLOCKADE; D-ASPARTATE ANTAGONIST; EVOKED-POTENTIALS; OSCILLATIONS; DISORDER; INTERNEURONS; MECHANISMS; FREQUENCY; EFFICACY; TRIAL;
D O I
10.1016/j.pbb.2020.172856
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Over the last two decades, the discovery of ketamine's antidepressant properties has galvanized research into the neurobiology of treatment-resistant depression. Nevertheless, the mechanism of action underlying antidepressant response to ketamine remains unclear. This study reviews electrophysiological studies of ketamine's effects in individuals with depression as well as healthy controls, with a focus on two putative markers of synaptic potentiation: gamma oscillations and long-term potentiation. The review focuses on: 1) measures of gamma oscillations and power and their relationship to both acute, psychotomimetic drug effects as well as delayed antidepressant response in mood disorders; 2) changes in long-term potentiation as a promising measure of synaptic potentiation following ketamine administration; and 3) recent efforts to model antidepressant response to ketamine using novel computational modeling techniques, in particular the application of dynamic causal modeling to electrophysiological data. The latter promises to better characterize the mechanisms underlying ketamine's antidepressant effects.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S
  • [32] Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression
    Mohazzab-Hosseinian, Sahra
    Kadriu, Bashkim
    Zandi, Peter
    Zarate, Carlos
    Goes, Fernando
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 318 - 319
  • [33] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
  • [34] Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression
    Souery, Daniel
    Serretti, Alessandro
    Calati, Raffaella
    Oswald, Pierre
    Massat, Isabelle
    Konstantinidis, Anastasios
    Linotte, Sylvie
    Bollen, Joseph
    Demyttenaere, Koen
    Kasper, Siegfried
    Lecrubier, Yves
    Montgomery, Stuart
    Zohar, Joseph
    Mendlewicz, Julien
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (04) : 512 - 516
  • [35] Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study
    Kang, Melody J. Y.
    Vazquez, Gustavo H.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 331 - 337
  • [36] Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
    Wilkinson, Samuel T.
    Rhee, Taeho Greg
    Joormann, Jutta
    Webler, Ryan
    Lopez, Mayra Ortiz
    Kitay, Brandon
    Fasula, Madonna
    Elder, Christina
    Fenton, Lisa
    Sanacora, Gerard
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2021, 90 (05) : 318 - 327
  • [37] Ketamine for Suicidal Behavior in Treatment-Resistant Depression: A Comparative Analysis of Antisuicidal and Antidepressant Effects
    Bandeira, Igor D.
    Tucciarone, Jason
    Kratter, Ian H.
    Heifets, Boris D.
    Schatzberg, Alan F.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 191 - 191
  • [38] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [39] Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage
    Scheele, Dirk
    Zimbal, Sophia
    Feinstein, Justin S.
    Delis, Achilles
    Neumann, Claudia
    Mielacher, Clemens
    Philipsen, Alexandra
    Hurlemann, Rene
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (12) : 982 - 986
  • [40] Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
    Zheng, Wei
    Zhou, Yan-Ling
    Wang, Cheng-Yu
    Lan, Xiao-Feng
    Zhang, Bin
    Yang, Ming-Zhe
    Nie, Sha
    Ning, Yu-Ping
    PEERJ, 2020, 8